5 ASX shares that I think are your best bet on Melbourne Cup Day

These 5 ASX companies look good value on Melbourne Cup Day

a woman

The Melbourne Cup is a day for punters to aim for the sky and hope for big returns and whilst some punters might disagree, I think you have a better shot investing in the ASX.

Here are five shares that I think are your best bet on Melbourne Cup Day.

Volpara Health Technologies Ltd (ASX: VHT)

Volpara is using artificial intelligence (AI) to improve the quality of breast cancer screening and its software as a service (SAAS) model provides plenty of annual recurring revenue. Despite some huge gains (almost 200% since 2016), it has a market cap of only $240 million. Volpara's opportunity is huge and so whilst the road ahead might be filled with lots of volatility, I like its long-term prospects.

Praemium Ltd (ASX: PPS)

The Praemium share price is down 33% since its peak when the recent market turmoil started but the business itself is doing well. The high growth fintech company just recently passed $8.5 billion in funds under administration and tailwinds within the superannuation and pension fund industry could propel it further forward.

Afterpay Touch Group Ltd (ASX: APT)

Afterpay divides opinions but it is taking on big markets and it has a very popular brand. Credit card usage is high enough in Australia, but it's significantly higher in the UK and the US, markets that Afterpay is targeting. If it can get just a small slice of those markets, it could provide huge returns. I don't expect it to be a smooth ride but if it pays off, patient shareholders will be rewarded.

Xero Limited (ASX: XRO)

It's hard to appreciate just how revolutionary Xero's product is if you are not an accountant or if you don't work in a small business. This company makes life easy for its users and it has a very sticky product that is difficult to replace which makes for an attractive investment.

CSL Limited (ASX: CSL)

Despite its recent share price drop, CSL's profit margins are expanding, it's forecasting a 10% – 14% underlying profit growth and it remains one of the ASX's premier biotechnology companies along with Mayne Pharma Group Ltd (ASX: MYX). Perhaps because of its size, it won't have the highest returns on the ASX, but it has a high-quality business and adding those to a portfolio is rarely a mistake in the long run.

If you are looking for more high growth innovative companies, read this report.

Motley Fool contributor Kevin Gandiya owns shares of AFTERPAY T FPO. You can find Kevin on Twitter @KevinGandiya. The Motley Fool Australia owns shares of and has recommended VOLPARA FPO NZ. The Motley Fool Australia owns shares of AFTERPAY T FPO and Xero. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

Young successful engineer, with blueprints, notepad, and digital tablet, observing the project implementation on construction site and in mine.
Broker Notes

Why the Paladin Energy share price "doesn't make sense"

This uranium stock could be set for a major re-rating.

Read more »

Girl with painted hands.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a remarkably positive end to the trading week.

Read more »

Two miners standing together.
Broker Notes

3 ASX 200 mining shares to buy with 41% to 79% upside ahead: broker

The green energy transition and other factors are providing strong growth drivers for mining.

Read more »

Happy miner with his arms folded.
Broker Notes

Buy, hold, sell: Paladin Energy, Fortescue, Rio Tinto shares

Let's take a look at some new ratings from Morgans.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

9 ASX 200 shares experts are backing for growth amid market weakness

Brokers retained a positive view on BHP, CSL, Telstra, Xero, and other shares this week. 

Read more »

One large yellow sphere on one side of a white seesaw, with a small yellow sphere on the other side.
Opinions

I investigated 3 ASX shares that have fallen sharply. Are they bargains or value traps?

I've given my verdict on three depressed high-profile stocks.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

This ASX biotech could rise 40% or 750%, depending on who you ask

A poor quarter has reduced expectations, but there's still plenty of upside.

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Opinions

These are the best 3 ASX growth shares I own and I'd buy more of today

I’m bullish about the earnings potential of these three ASX growth shares.

Read more »